Compare VanEck Video Gaming and eSports ETF (ESPO) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Video Gaming and eSports ETF vs Pfizer Inc — how do they compare? VanEck Video Gaming and eSports ETF trades at $97.96, while Pfizer Inc trades at $26.32 (market cap $151.73B). The key difference: Pfizer Inc pays a 6.46% dividend while VanEck Video Gaming and eSports ETF pays none, and Pfizer Inc is trading nearer its 52-week high, VanEck Video Gaming and eSports ETF nearer its low. Which is the better fit depends on your goals.
| ESPO | PFE | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $122.30 | $28.56 |
52-Week Low | $85.25 | $23.60 |
Market Cap | — | $151.73B |
Volume | — | 29,869,932 |
Enterprise Value | — | $203.22B |
Dividend Yield | — | 6.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ESPO trades at $97.98, down 1.63% today, with technical indicators showing a bullish bias as moving averages and oscillators signal buying opportunities. The stock shows strong momentum with ADX readings indicating a trending market. Support levels are established at $96, $97, and $98, while resistance sits at $100, $101, and $102.
The bullish technical setup suggests potential upside toward resistance levels, though fundamental analysis is limited due to unavailable financial ratios. Investors should monitor upcoming earnings reports for revenue growth and profitability metrics to validate the technical strength with fundamental support.
Pfizer (PFE) trades at $27.05, up 1.16% with a bullish technical signal and consistent earnings beats in recent quarters. Revenue remains stable around $62-63 billion, though net income is projected to decline in 2026. The stock shows strong profitability margins and a solid balance sheet, but faces headwinds from patent expirations and competitive pressures.
The outlook is mixed: valuation multiples appear reasonable, and analyst consensus leans hold with a $27.86 target. Key risks include execution on pipeline catalysts and margin compression. Upside depends on successful drug launches and cost management amid a challenging revenue environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Video Gaming and eSports ETF
ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.
Read more on ESPO →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
